skip to Global Navigation Bar
skip to main content
Global Business
Introduction
Strategy
Manufacturing
Licensing Opportunities
Contact Us
R&D
Introduction
Global R D
Pipeline
Our Needs
Products
Products Search
Global Brand
In-License
Introduction
Strategy
No.1 Position
Core-Competency
Licensed Products
Partnership
Investors
Management information
Financial information
Stock condition
IR information
Press Release
News
PR Video
About Us
Company Profile
CEO Message
Recruitment
· News
· PR Video
Home > Press Release >
News
뉴스
No
Subject
Data
175
Daewoong signs 3-party MOU with CGBio-VANCIVE
2014-06-17
174
‘Impectamin’ changes the paradigm in the Vitamin B market
2014-06-13
173
NABOTA received approval from Thailand
2014-06-09
172
Daewoong Pharmaceutical inks contracts to export Caretropin, a liquid growth hormone product, and syringes to three countries
2014-05-26
171
Pharmaceutical safety management officials of Southeast Asian countries visited Daewoong Pharmaceutical
2014-04-28
170
Daewoong Pharmaceutical set up Compliance Team to spur business transparency
2014-04-22
169
Daewoong Pharmaceutical joins forces with Daiichi Sankyo Korea for co-promotion of ‘OLOSTAR’
2014-04-18
168
Daewoong Pharmaceutical announced its vision for ‘NABOTA’ sweeping the global botulinum toxin market
2014-04-16
167
Imatinib, a drug for the treatment of chronic myelogenous leukemia, makes full-scale entry into Iranian market
2014-04-10
166
Daewoong Pharmaceutical and Daewoong Bio made their presence felt at CPhl Japan and CPhI Russia
2014-04-09
1
/
2
/
3
/
4
/
5
/
6
/
7
/
8
/
9
/
10
/
News Search
subject
content
Home > Press Release > News
Home > Press Release > News